Helicobacter pylori infection caused an estimated 760,000 new stomach cancer cases in 2024, about three-quarters of the nearly 1 million global total, the International Agency for Research on Cancer reported.
Almost 1 million people developed stomach cancer worldwide in 2024, with bacterial infections driving the majority of the global burden, according to data released on Nov. 3, 2026.
Researchers at the International Agency for Research on Cancer reported that nearly 650,000 people died from the disease globally, placing it as the fifth most common cancer type and the fifth leading cause of cancer-related death.
Almost two thirds of both new cases and deaths occurred among men, with Asia carrying the largest burden.
China alone accounted for more than one third of all new cases and deaths worldwide, reflecting sharp regional differences in disease distribution.
The bacterium is a spiral-shaped microorganism that infects the stomach lining, often acquiring during childhood and persisting for decades.
The International Agency for Research on Cancer classifies it as a Group 1 carcinogen because persistent infection causes chronic inflammation that can gradually damage the stomach lining over time.
This chronic inflammation can trigger a multi-stage progression known as the Correa cascade, leading through atrophic gastritis and intestinal metaplasia toward dysplasia and adenocarcinoma.
However, most individuals infected with the bacterium never develop cancer, as progression depends on bacterial virulence, genetic susceptibility, and environmental factors.
Awareness of the disease expanded significantly after No Stomach For Cancer, a nonprofit organization established in 2009, worked with the United States Senate to secure November as Gastric Cancer Awareness Month.
That advocacy led to Senate Resolution 655, introduced by Senator Russ Feingold and co-sponsored by Senator Dick Durbin in 2010.
Early-stage disease frequently produces few or no symptoms, complicating detection.
When symptoms do appear, they often mirror common gastrointestinal conditions, including persistent upper abdominal discomfort, unexplained weight loss, and early satiety.
Doctors rely primarily on upper gastrointestinal endoscopy with biopsy to investigate suspicious changes in the stomach lining.
Diagnostic workups also utilize computed tomography scans, endoscopic ultrasound, and biomarker testing for HER2, PD-L1, MSI/dMMR, and CLDN18.2 to guide treatment decisions.
While antibiotics can treat the bacterial infection, researchers note that large-scale treatment programs must carefully weigh the benefits against the risk of contributing to antibiotic resistance.
Serving as an intergovernmental agency forming part of the World Health Organization of the United Nations, the International Agency for Research on Cancer conducts and coordinates research into the causes of cancer while collecting and publishing surveillance data regarding the occurrence of cancer worldwide. Its role includes operating the IARC monographs programme, through which IARC Working Groups identify carcinogenic hazards and evaluate environmental causes of cancer in humans.
Ongoing research focuses on evaluating the feasibility of screening programs and establishing global prevention guidelines.
Keep reading
- Vivek Subbiah: FDA Label Imprecision on Daraxonrasib Is Beneficial
- Byron Native Dr. Ellie Wolf Opens Wolf Wellness Family Chiropractic in Oregon Nov. 30
- Mississippi Mother, Caregiver Charged With Murder After Refusing Toddler Cancer Treatment (news-usa.today)
- 90-Year-Old Drives Wrong Way 35 km on A75 in Lozère Before Police Stop (archyde.com)